FDA 483 - Women's Fertility and Health Center - April 19, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA issued a Form 483 to Women's Fertility and Health Center following an inspection of their human reproductive tissue establishment. The inspection revealed significant deficiencies in donor screening for communicable disease risks, a lack of established procedures for donor eligibility determination, and failures in proper identification and labeling of HCT/Ps. These issues indicate a potential risk to the safety and quality of human cells, tissues, and cellular and tissue-based products.
ID · 732d8661-51af-4294-8704-6642b08165a0